Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd.

NASDAQ:WVE

Overview | Financials
Company Name Wave Life Sciences Ltd.
Symbol WVE
Currency USD
Price 14.61
Market Cap 2,263,483,470
Dividend Yield 0%
52-week-range 3.5 - 15.92
Industry Biotechnology
Sector Healthcare
CEO Dr. Paul B. Bolno M.B.A., M.D., MBA
Website https://www.wavelifesciences.com

An error occurred while fetching data.

About Wave Life Sciences Ltd.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression.

Related Stocks

Vigil Neuroscience, Inc. logo

Vigil Neuroscience, Inc.

VIGL

3.99 USD

SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc.

SABS

2.76 USD

Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc.

ASMB

18.1 USD

BioAtla, Inc. logo

BioAtla, Inc.

BCAB

1.85 USD

Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc.

ETON

8.4 USD

Lipocine Inc. logo

Lipocine Inc.

LPCN

5.04 USD

Akumin Inc. logo

Akumin Inc.

AKU

0.289 USD

aTyr Pharma, Inc. logo

aTyr Pharma, Inc.

LIFE

1.9 USD

Financials

Numbers are in millions USD

Numbers are in millions USD